News Letter to Shareholders and Corporate Update Continue Reading Previous Sandoz announces exclusive deal to commercialize biosimilar ustekinumab, further reinforcing growing pipeline and immunology patient offeringNext Verona Pharma Announces the US FDA has Accepted the New Drug Application Filing for Ensifentrine for the Maintenance Treatment of COPD Related Stories News i10X launches Superagent News Beebole launches a fully rebuilt platform after 18 years of independent, founder-led growth News CTO Confidence in Scaling AI Falls for Third Straight Year, Akkodis Report Finds News CTO Confidence in Scaling AI Falls for Third Straight Year, Akkodis Report Finds News Anker Innovations announces the listing plan on the Main Board of HKEX with a maximum fundraising of HK$4,631.6 Million* News Anker Innovations announces the listing plan on the Main Board of HKEX with a maximum fundraising of HK$4,631.6 Million*
